0 results available. Select is focused ,type to refine list, press Down to open the menu,
Talphera, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for use in medically supervised settings. Its lead product candidate is Niyad, a lyoph...
The following section summarizes insights on Talphera Inc's Capital Expenditures:
We've identified the following companies as similar to Talphera Inc because they operate in a related industry or sector. We also considered size, growth, and various financial metrics to narrow down the list to the ones listed below.
To view the full list of supported financial metrics please see Complete Metrics Listing.
Metrics similar to Capital Expenditures in the financials category include:
The overall change in capital expenditures and sales of plant, property and equipment. This field is used if a company does not report separately sale...
Capital expenditures or CAPEX represents spending on assets that are enjoyed over a long period of time. Common examples of capital expenditures include office buildings, machines, and vehicles.
Capital expenditures can be found on a company’s cash flow statement under “Investing Activities” and increases fixed assets located on the Balance Sheet
Talphera reported capital expenditures of 100 T for the latest twelve months ending September 30, 2024 on its income statement.
The tables below summarizes Talphera’s capital expenditures and common size over the last five years:
| Fiscal Year | Capital Expenditures | Revenue | % Revenue |
|---|---|---|---|
| 2019-12-31 | 3.47 M | 2.289 M | 151.6% |
| 2020-12-31 | 1.855 M | 5.416 M | 34.3% |
| 2021-12-31 | 1.827 M | 378 T | 483.3% |
| 2022-12-31 | 364 T | NA | NA |
| 2023-12-31 | 100 T | 651 T | 15.4% |
The tables below summarizes Talphera’s capital expenditures and common size over the last four quarters:
| Quarter Ending | Capital Expenditures | Revenue | % Revenue |
|---|---|---|---|
| 2023-12-31 | zero | 281 T | 0.0% |
| 2024-03-31 | NA | NA | NA |
| 2024-06-30 | NA | NA | NA |
| 2024-09-30 | NA | NA | NA |
The chart above depicts the distribution of capital expenditures for companies operating in the Healthcare sector in the Developed economic region. Over 2,020 companies were considered in this analysis, and 1,958 had meaningful values. The average capital expenditures of companies in the sector is 25.822 M with a standard deviation of 86.497 M.
Talphera Inc's Capital Expenditures of 100 K ranks in the 30.5% percentile for the sector. The following table provides additional summary stats:
| Economic Risk Region | Developed |
| Total Constituents | 2,024 |
| Included Constituents | 1,958 |
| Min | 0 K |
| Max | 755 M |
| Median | 521.768 K |
| Mean | 25.822 M |
| Standard Deviation | 86.497 M |
You can find companies with similar capital expenditures using this stock screener.